Health Care & Life Sciences » Biotechnology | Immuno-Biological Laboratories Co. Ltd.

Immuno-Biological Laboratories Co. Ltd.

Immuno-Biological Laboratories Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY4.24
Market Cap
JPY7.45 B
Shares Outstanding
8.42 M
Public Float
6.33 M

Profile

Address
1091-1 Naka Aza-Higashida
Fujioka Gumma 375
Japan
Employees -
Website http://www.ibl-japan.co.jp
Updated 09/14/2018
Immuno-Biological Laboratories Co., Ltd. engages in the manufacture and sale of antibody-related reagents and pharmaceutical products. It operates through the following segments: Diagnostics and Reagents, Genetically Modified Silkworm, Testing, and Cosmetics-related. The Diagnostics and Reagents segment deals with the research and development of reagents and pharmaceutical products as well as in vitro diagnostic pharmaceuticals.

Financials

View All

Masato Nakagawa
Director & GM-Group Business Administration
Masahiro Maeda
Director & Manager-Clinical Testing Business